Home
Conditions
Recurrent Adult Acute Myeloid Leukemia

Clinical trial condition

Recurrent Adult Acute Myeloid Leukemia

Explore clinical trials studying Recurrent Adult Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

142 public trials 4 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Adult Acute Myeloid Leukemia trial results

Recruiting

Personalized NK Cell Therapy in CBT

NCT02727803

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma

NCT03017820

Conditions: B-Cell Non-Hodgkin Lymphoma, Blood Protein Disorders, Bone Marrow Diseases, +46 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Recruiting

CD33-CAR T Cell Therapy for the Treatment of Recurrent or Refractory Acute Myeloid Leukemia

NCT05672147

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

A Prospective, Multicenter, and Exploratory Study of CMGV in the Treatment of Recurrent Adult AML and MDS-EB-2/Elder AML

NCT06329999

Conditions: Adult Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +9 more
Locations: Ruijin Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Active, not recruiting

Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia

NCT00392353

Conditions: Acute Erythroid Leukemia, Acute Megakaryoblastic Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, +27 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States

North Shore University Hospital Manhasset, New York, United States

Mount Sinai Hospital New York, United States

View Trial Details

Active, not recruiting

Bortezomib, Sorafenib Tosylate, and Decitabine in Treating Patients With Acute Myeloid Leukemia

NCT01861314

Conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Post Cytotoxic Therapy, Hematologic Diseases, +8 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Active, not recruiting

Total Marrow and Lymphoid Irradiation and Chemotherapy Before DSCT in Treating Patients With High-Risk ALL or AML

NCT02094794

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +22 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant

NCT01199562

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +245 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Active, not recruiting

Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid Leukemia

NCT03513484

Conditions: Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, FLT3 Internal Tandem Duplication, Fibroblast Growth Factor Basic Form Measurement, +9 more
Locations: Northwestern University Chicago, Illinois, United States

View Trial Details

Active, not recruiting

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

NCT02159495

Conditions: Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Adult Acute Lymphoblastic Leukemia, +35 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recurrent Adult Acute Myeloid Leukemia

Recurrent Adult Acute Myeloid Leukemia trial results

Related conditions